Paszek E - Search Results

1

Elevated plasma factor XI predicts cardiovascular events in patients with type 2 diabetes: a long-term observational study.

Paszek E, Polak M, Bryk-Wiązania AH, Konieczyńska M, Undas A. Paszek E, et al. Cardiovasc Diabetol. 2023 Jul 17;22(1):182. doi: 10.1186/s12933-023-01905-5. Cardiovasc Diabetol. 2023. PMID: 37460982 Free PMC article.

2

Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.

Bala MM, Paszek E, Lesniak W, Wloch-Kopec D, Jasinska K, Undas A. Bala MM, et al. Among authors: paszek e. Cochrane Database Syst Rev. 2018 Jul 13;7(7):CD012534. doi: 10.1002/14651858.CD012534.pub2. Cochrane Database Syst Rev. 2018. PMID: 30004572 Free PMC article. Review.

3

Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.

Paszek E, Pociask E, Ząbczyk M, Piórkowski A, Butenas S, Legutko J, Undas A. Paszek E, et al. Atherosclerosis. 2022 Apr;346:124-132. doi: 10.1016/j.atherosclerosis.2022.02.009. Epub 2022 Feb 11. Atherosclerosis. 2022. PMID: 35246318

4

Activated factor XI is associated with increased factor VIIa - Antithrombin complexes in stable coronary artery disease: Impact on cardiovascular outcomes.

Paszek E, Pociask E, Ząbczyk M, Butenas S, Undas A. Paszek E, et al. Eur J Clin Invest. 2022 Dec;52(12):e13857. doi: 10.1111/eci.13857. Epub 2022 Aug 29. Eur J Clin Invest. 2022. PMID: 35996895

5

Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.

Paszek E, Malinowski KP, Ząbczyk M, Butenas S, Undas A. Paszek E, et al. Eur J Clin Invest. 2023 Sep;53(9):e14007. doi: 10.1111/eci.14007. Epub 2023 Apr 21. Eur J Clin Invest. 2023. PMID: 37042848

6

Therapy with ticagrelor/prasugrel is associated with enhanced fibrinolysis and suppressed platelet activation as compared to clopidogrel in chronic coronary syndrome.

Paszek E, Natorska J, Ząbczyk M, Klajmon A, Undas A. Paszek E, et al. Kardiol Pol. 2023;81(11):1130-1133. doi: 10.33963/v.kp.97391. Epub 2023 Sep 18. Kardiol Pol. 2023. PMID: 37718582 Free article. No abstract available.

7

Evaluation of profilin 1 as a biomarker in myocardial infarction.

Paszek E, Żmudka K, Plens K, Legutko J, Rajs T, Zajdel W. Paszek E, et al. Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8112-8116. doi: 10.26355/eurrev_202008_22497. Eur Rev Med Pharmacol Sci. 2020. PMID: 32767339 Free article.

8

Percutaneous management of long and diffused coronary lesions using newer generation drug-eluting stents in routine clinical practice: long-term outcomes and complication predictors.

Paszek E, Zajdel W, Musiałek P, Sokołowski A, Guzik B, Kabłak-Ziembicka A, Niewiara Ł, Pankowska M, Mielimonka A, Żmudka K. Paszek E, et al. Pol Arch Intern Med. 2019 Jun 28;129(6):392-398. doi: 10.20452/pamw.14864. Epub 2019 Jun 6. Pol Arch Intern Med. 2019. PMID: 31169263 Free article.

9

Profilin 1 and Mitochondria-Partners in the Pathogenesis of Coronary Artery Disease?

Paszek E, Zajdel W, Rajs T, Żmudka K, Legutko J, Kleczyński P. Paszek E, et al. Int J Mol Sci. 2021 Jan 22;22(3):1100. doi: 10.3390/ijms22031100. Int J Mol Sci. 2021. PMID: 33499277 Free PMC article. Review.

10

Role of the Wnt signalling pathway in the development of endothelial disorders in response to hyperglycaemia.

Durak-Kozica M, Paszek E, Stępień EŁ. Durak-Kozica M, et al. Among authors: paszek e. Expert Rev Mol Med. 2019 Dec 4;21:e7. doi: 10.1017/erm.2019.8. Expert Rev Mol Med. 2019. PMID: 31796147 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22 results

Search Page